BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $224,000 | -64.7% | 11,698 | -41.1% | 0.01% | -66.7% |
Q2 2021 | $635,000 | +6.2% | 19,850 | 0.0% | 0.02% | -4.5% |
Q1 2021 | $598,000 | -30.3% | 19,850 | +0.1% | 0.02% | -29.0% |
Q4 2020 | $858,000 | -17.2% | 19,821 | +3.2% | 0.03% | -31.1% |
Q3 2020 | $1,036,000 | -8.3% | 19,205 | +3.7% | 0.04% | -10.0% |
Q2 2020 | $1,130,000 | +48.5% | 18,516 | +11.8% | 0.05% | +38.9% |
Q1 2020 | $761,000 | -39.5% | 16,558 | +15.6% | 0.04% | +2.9% |
Q4 2019 | $1,257,000 | -6.4% | 14,327 | -2.1% | 0.04% | 0.0% |
Q3 2019 | $1,343,000 | -27.3% | 14,630 | +0.7% | 0.04% | -25.5% |
Q2 2019 | $1,848,000 | -21.7% | 14,530 | -3.2% | 0.05% | -21.7% |
Q1 2019 | $2,361,000 | +58.7% | 15,005 | 0.0% | 0.06% | +57.9% |
Q4 2018 | $1,488,000 | -34.3% | 15,005 | -3.3% | 0.04% | -29.6% |
Q3 2018 | $2,266,000 | +6.6% | 15,523 | +14.6% | 0.05% | +5.9% |
Q2 2018 | $2,125,000 | -35.5% | 13,542 | -29.8% | 0.05% | -39.3% |
Q1 2018 | $3,293,000 | +49.9% | 19,287 | +56.3% | 0.08% | +47.4% |
Q4 2017 | $2,197,000 | -16.2% | 12,337 | -35.4% | 0.06% | -16.2% |
Q3 2017 | $2,622,000 | – | 19,090 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
Summit X, LLC | 103,424 | $651,000 | 0.19% |